PFZ.L Share News (PFZ)
PFZ Share
PFZ Share
PFZ Share
PFZ Share
PFZ
PFZ Share
PFZ Broker
PFZ Directors
PFZ Financial
PFZ
PFZ Short
PFZ
(Sharecast News) - Pfizer shares were in the green in early Wall Street trading on Tuesday, as the pharmaceutical giant hiked its outlook on the back of a third-quarter earnings beat.
Read more(Sharecast News) - Full results from the clinical trial evaluating the efficacy and safety of the vaccine against Covid-19 developed by Pfizer and BioNTech in adolescents showed that it was 100% effective with no serious safety concerns.
Read more(Sharecast News) - Drug giant Pfizer blew past analysts' forecasts for its third quarter, beating on both its top and bottom line and guiding the market consensus higher.
Read more(Sharecast News) - Drugmaker Pfizer posted first-quarter earnings and revenues that came in ahead of Wall Street expectations on Tuesday, with the group upping full-year guidance on the back of strong sales of its Covid-19 vaccine.
Read more(Sharecast News) - The Covid-19 vaccine from Pfizer and BioNTech was able to neutralize the new Brazilian variant of the SARS-CoV-2 coronavirus, according to a laboratory study published in the New England Journal of Medicine on Monday.
Read more(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.
Read more(Sharecast News) - Pfizer and Moderna on Tuesday said they were testing their Covid-19 vaccines against the new mutated version of the virus recently discovered in the UK.
Read more(Sharecast News) - Britain has become the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine for use, with doses to be rolled out from early next week.
Read more(Sharecast News) - Britain's drug regulator has reportedly started an accelerated reviews of Covid-19 vaccines under development from Pfizer and AstraZeneca.
Read more(Sharecast News) - Moderna's Covid-19 vaccine candidate could be ready for use in December, the company's boss said.
Read more(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.
Read more(Sharecast News) - Shares of drug giant Pfizer were boosted by news of positive clinical trial results for a Covid-19 vaccine candidate known as BNT162b1.
Read more(Sharecast News) - BioNTech and Pfizer finished dosing the first group of subjects for their Phase 1/2 clinical trial for the BNT162 vaccine against Covid-19 and will help China's Fosun Pharma to do the same.
Read more(ShareCast News) - Drug maker Allergan confirmed on Thursday that it has received an approach from Pfizer Inc regarding a potential combination. Allergan said the two were in "preliminary friendly discussions", adding that no agreement has been reached and there can be no certainty the talks will le
Read moreShares in takeover target Shire took a beating on Wednesday as US lawmakers demanded a crackdown on US companies basing themselves abroad to cut their tax bills. The British drug company's stock closed 79p down at 4786p in London as US Treasury Secretary Jacob Lew urged leaders of the congressional
Read more